Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Pediatric Endocrinology · Combined Pituitary Hormone Deficiency

Standard Treatment and Building Your Care Team

At a Glance

The primary treatment for Combined Pituitary Hormone Deficiency (CPHD) is lifelong hormone replacement therapy overseen by a pediatric endocrinologist. It is critical that cortisol replacement begins before or alongside thyroid medication to prevent a life-threatening adrenal crisis.

Managing Combined Pituitary Hormone Deficiency (CPHD) requires a lifelong commitment to hormone replacement therapy. Because your child’s body does not produce these essential chemical messengers, the goal of treatment is to provide them in the correct amounts to support growth, energy, and overall health [1][2].

The Golden Rule of Treatment

There is one critical rule that every parent and doctor must follow when starting treatment: Cortisol must be addressed first.

If your child is deficient in both cortisol (the stress hormone) and thyroid hormone, they must start taking hydrocortisone before or at the exact same time as levothyroxine (thyroid medication) [3][4].

Why this matters: Thyroid hormone speeds up the body’s metabolism. If you give thyroid hormone alone, it causes the body to use up its remaining cortisol much faster than normal [3]. In a child whose body cannot make more cortisol to keep up, this can trigger a life-threatening adrenal crisis [3][4]. Your doctor will carefully coordinate these start dates to keep your child safe [5].

Common Hormones Replaced in CPHD

Most children with CPHD will require a combination of the following therapies [6]:

  • Hydrocortisone: Replaces cortisol. This is vital for managing physical stress, like illness or injury [7][8].
  • Levothyroxine: Replaces thyroid hormone to support brain development and metabolism [9][10].
  • Growth Hormone (rhGH): Given as a daily or once-weekly injection to help your child reach their genetic height potential and maintain healthy body composition [11][2]. Note: While the idea of injections can be intimidating, the needles used today are incredibly small, and modern devices are highly child-friendly. Your medical team will fully train you, and the routine quickly becomes a normal part of the day.
  • Desmopressin (DDAVP): If the posterior pituitary is affected (causing Diabetes Insipidus), this medication replaces Anti-Diuretic Hormone (ADH) to control extreme thirst and prevent dangerous dehydration [12][13].
  • Sex Hormones: As your child reaches teenage years, they may need testosterone or estrogen to begin and complete puberty [6][14].

Building Your Care Team

Because CPHD affects multiple systems, your child will benefit from a “medical home” led by specialists [6][15]. Your care team should include:

  1. Pediatric Endocrinologist: The “captain” of the team who manages hormone dosing and monitors growth [6][16].
  2. Clinical Geneticist: Helps identify the specific genetic cause (the “blueprint error”), which can help predict if other health issues might arise and provide information for other family members [16][17].
  3. Ophthalmologist: Essential for checking the optic nerves, especially if your child has a condition like Septo-optic Dysplasia [18][19].
  4. Pediatrician: Manages your child’s routine health and coordinates with the specialists [15][14].

Finding Support: Connecting with patient advocacy groups, such as the MAGIC Foundation or the Pituitary Network Association, can provide your family with invaluable community support, educational resources, and a network of other families navigating the same diagnosis.

Regular follow-up is necessary because hormone needs change as a child grows, and new deficiencies can sometimes develop years after the initial diagnosis [1][20]. Through consistent monitoring and a strong care team, children with CPHD can lead full, active lives [21][22].

Common questions in this guide

Why must hydrocortisone be started before levothyroxine for CPHD?
Starting thyroid medication speeds up the body's metabolism. If started before cortisol replacement, it can cause the body to rapidly use up its remaining cortisol, potentially triggering a life-threatening adrenal crisis.
What hormones typically need to be replaced in a child with CPHD?
Most children require replacement of cortisol with hydrocortisone, thyroid hormone with levothyroxine, and growth hormone. Depending on the specific deficiencies, they may also need desmopressin for diabetes insipidus or sex hormones during puberty.
Which doctors should be on my child's CPHD care team?
A pediatric endocrinologist usually leads the care team. Other essential specialists often include a clinical geneticist, an ophthalmologist to check optic nerves, and a general pediatrician to manage routine health and coordinate care.
How is growth hormone administered for children with CPHD?
Growth hormone is typically given as a daily or once-weekly injection to help children reach their normal height potential and maintain healthy body composition. Modern devices are very child-friendly, and your medical team will teach you how to use them safely.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with CPHD or panhypopituitarism do you currently manage in your practice?
  2. 2.Can you explain the exact timing of our first doses of hydrocortisone and levothyroxine to ensure we avoid an adrenal crisis?
  3. 3.Who on the team is our primary point of contact for 'sick day' emergencies after hours?
  4. 4.Which other specialists, such as a geneticist or ophthalmologist, do you recommend we add to our care team immediately?
  5. 5.How do you determine if my child's growth hormone dose needs to be adjusted as they grow?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Progression from isolated growth hormone deficiency to combined pituitary hormone deficiency.

    Cerbone M, Dattani MT

    Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2017; (37()):19-25 doi:10.1016/j.ghir.2017.10.005.

    PMID: 29107171
  2. 2

    TRENDS IN GROWTH HORMONE STIMULATION TESTING AND GROWTH HORMONE DOSING IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: RESULTS FROM THE ANSWER PROGRAM.

    Gordon MB, Levy RA, Gut R, Germak J

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2016; (22(4)):396-405 doi:10.4158/EP14603.OR.

    PMID: 26574788
  3. 3

    Subclinical hypothyroidism or central hypothyroidism-The danger of thyroid function misinterpretation.

    Anyiam O, Cheung B, Al-Sabbagh S

    Clinical case reports 2018; (6(10)):1953-1957 doi:10.1002/ccr3.1694.

    PMID: 30349705
  4. 4

    Lessons of the month: A challenging presentation of hypopituitarism secondary to an intracerebral aneurysm.

    Mullarkey EM, Iyer A, Ihuoma A

    Clinical medicine (London, England) 2021; (21(2)):e228-e230 doi:10.7861/clinmed.2020-1017.

    PMID: 33762391
  5. 5

    Central adrenal insufficiency: who, when, and how? From the evidence to the controversies - an exploratory review.

    Bitencourt MR, Batista RL, Biscotto I, Carvalho LR

    Archives of endocrinology and metabolism 2022; (66(4)):541-550.

    PMID: 35758836
  6. 6

    Overview of Congenital Hypopituitarism for the Neonatologist.

    Bautista G

    NeoReviews 2022; (23(5)):e300-e310 doi:10.1542/neo.23-5-e300.

    PMID: 35490188
  7. 7

    A newborn with combined pituitary hormone deficiency developing shock and sludge.

    Ueda Y, Aoyagi H, Tajima T

    Journal of pediatric endocrinology & metabolism : JPEM 2017; (30(12)):1333-1336.

    PMID: 29176025
  8. 8

    Novel compound heterozygous variants in the LHX3 gene caused combined pituitary hormone deficiency: A case report.

    Lin SZ, Ma QJ, Pang QM, et al.

    World journal of clinical cases 2022; (10(31)):11486-11492 doi:10.12998/wjcc.v10.i31.11486.

    PMID: 36387827
  9. 9

    TSH and FT4 Concentrations in Congenital Central Hypothyroidism and Mild Congenital Thyroidal Hypothyroidism.

    Zwaveling-Soonawala N, van Trotsenburg ASP, Verkerk PH

    The Journal of clinical endocrinology and metabolism 2018; (103(4)):1342-1348 doi:10.1210/jc.2017-01577.

    PMID: 29325028
  10. 10

    Clinical and genetic characteristics of Dutch children with central congenital hypothyroidism, early detected by neonatal screening.

    Naafs JC, Verkerk PH, Fliers E, et al.

    European journal of endocrinology 2020; (183(6)):627-636.

    PMID: 33107432
  11. 11

    [Long-term follow-up data of patients with Multiple Pituitary Hormone Deficiency].

    Elvan-Tuz A, Bayramoglu E, Cetinkaya S

    Andes pediatrica : revista Chilena de pediatria 2023; (94(6)):689-697 doi:10.32641/andespediatr.v94i6.4680.

    PMID: 38329304
  12. 12

    Severe, persistent neonatal hypoglycemia as a presenting feature in patients with congenital hypopituitarism: a review of our case series.

    Mehta S, Brar PC

    Journal of pediatric endocrinology & metabolism : JPEM 2019; (32(7)):767-774.

    PMID: 31211689
  13. 13

    Dorsoventral splitting of the infundibulum in a child with pituitary hypoplasia.

    Welby JP, Madhavan AA, Campeau NG, et al.

    Radiology case reports 2023; (18(8)):2754-2757 doi:10.1016/j.radcr.2023.05.038.

    PMID: 37334326
  14. 14

    Management of Hypopituitarism.

    Alexandraki KI, Grossman A

    Journal of clinical medicine 2019; (8(12)) doi:10.3390/jcm8122153.

    PMID: 31817511
  15. 15

    Progress, challenges and perspectives in the management of hypopituitarism.

    Boguszewski CL, Neggers S

    Reviews in endocrine & metabolic disorders 2024; (25(3)):453-455 doi:10.1007/s11154-024-09889-7.

    PMID: 38801648
  16. 16

    Identification of POU1F1 Variants in Vietnamese Patients with Combined Pituitary Hormone Deficiency.

    Nguyen HT, Nguyen KN, Dien TM, et al.

    International journal of molecular sciences 2025; (26(6)) doi:10.3390/ijms26062406.

    PMID: 40141050
  17. 17

    SEMA3A and IGSF10 Are Novel Contributors to Combined Pituitary Hormone Deficiency (CPHD).

    Budny B, Zemojtel T, Kaluzna M, et al.

    Frontiers in endocrinology 2020; (11()):368 doi:10.3389/fendo.2020.00368.

    PMID: 32612575
  18. 18

    HESX1 mutations in patients with congenital hypopituitarism: variable phenotypes with the same genotype.

    Fang Q, Benedetti AF, Ma Q, et al.

    Clinical endocrinology 2016; (85(3)):408-14 doi:10.1111/cen.13067.

    PMID: 27000987
  19. 19

    A homozygous splice site ROBO1 mutation in a patient with a novel syndrome with combined pituitary hormone deficiency.

    Dateki S, Watanabe S, Mishima H, et al.

    Journal of human genetics 2019; (64(4)):341-346 doi:10.1038/s10038-019-0566-8.

    PMID: 30692597
  20. 20

    Clinical Characteristics of Children with Combined Pituitary Hormone Deficiency and the Effects of Growth Hormone Treatment.

    Besci Ö, Sevim RD, Acinikli KY, et al.

    Klinische Padiatrie 2025; (237(1)):11-20 doi:10.1055/a-2186-9304.

    PMID: 38049102
  21. 21

    Growth without growth hormone in combined pituitary hormone deficiency caused by pituitary stalk interruption syndrome.

    Lee SS, Han AL, Ahn MB, et al.

    Annals of pediatric endocrinology & metabolism 2017; (22(1)):55-59 doi:10.6065/apem.2017.22.1.55.

    PMID: 28443260
  22. 22

    Delayed diagnosis of congenital hypopituitarism associated with low socio-economic status and/or migration.

    Boros E, Casimir M, Heinrichs C, Brachet C

    European journal of pediatrics 2020; (179(1)):151-155 doi:10.1007/s00431-019-03489-3.

    PMID: 31691850

This page provides educational information about CPHD treatments and care teams. Always consult your pediatric endocrinologist for specific medical advice, especially regarding hormone dosing and sick day management.

Get notified when new evidence is published on Non-acquired combined pituitary hormone deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.